ICD-10-CM Billable Code

Z16.10

Resistance to unspecified beta lactam antibiotics

Clinical Classification Guidelines

Medical Intelligence & Overview

ICD-10 code Z16.10 pertains to resistance to unspecified beta-lactam antibiotics. This condition describes a scenario where bacteria no longer respond to certain antibiotics that belong to the beta-lactam class, which includes penicillins, cephalosporins, carbapenems, and monobactams. Antibiotic resistance is a significant concern in healthcare, leading to infections that are more difficult to treat and increasing the risk of complications. Recognizing and understanding this resistance helps in managing bacterial infections effectively and in taking appropriate precautions to prevent the spread of resistant bacteria.

Causes & Symptoms

Clinical Causes: Overuse or misuse of antibiotics, such as not completing prescribed courses or using antibiotics unnecessarily Repeated or prolonged exposure to antibiotics, leading bacteria to adapt and develop resistance Genetic mutations within bacteria that confer resistance traits Horizontal gene transfer among bacteria, spreading resistance genes Infection control failures in healthcare settings, facilitating the transmission of resistant bacteria

Key Symptoms: Persistent or worsening infection symptoms despite antibiotic treatment Relapse after initial improvement with antibiotics Infections that are harder to treat or take longer to resolve Possibility of more severe infections or complications, depending on the bacteria involved In cases where resistant bacteria cause specific infections, symptoms may align with the affected body system, such as respiratory, urinary, or skin infections

Diagnostic & Treatment

Diagnosis Path: Diagnosis of resistance to beta-lactam antibiotics typically involves laboratory testing, including bacterial cultures and sensitivity testing. These tests determine whether bacteria are resistant or sensitive to specific antibiotics, guiding effective treatment options. Molecular techniques such as PCR may also be used to identify resistance genes directly from bacterial samples. Clinicians rely on these laboratory results in conjunction with clinical evaluation to confirm resistance and tailor antibiotic therapy appropriately.

Treatment Protocols: Using antibiotics that the bacteria are still sensitive to, based on laboratory testing Combination antibiotic therapy to overcome resistance mechanisms Utilizing newer or less commonly used antibiotics with activity against resistant strains Supportive care to aid recovery and manage symptoms Implementing infection control measures to prevent spread within healthcare facilities Addressing underlying issues that contributed to resistance, such as discontinuing unnecessary antibiotic use

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is Z16.10 a billable ICD-10 code?
Yes, Z16.10 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report Z16.10?
Clinical documentation must specify the nature of Resistance to unspecified beta lactam antibiotics and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

lactam antibiotics resistance